Upregulation of ACE2-ANG-(1-7)-mas axis in jejunal enterocytes of type 1 diabetic rats: Implications for glucose transport

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 5, 2012, Pages

  Wong, Tung Po ^a   Ho, Ka Yan ^a   Ng, Enders K W ^a   Debnam, Edward S ^b   Leung, Po Sing ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiotensin (1 7); Angiotensin converting enzyme 2; Diabetes mellitus; Glucose transport; Mas receptor; Sodium dependent glucose transporter 1

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE CELL; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84865713693     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00562.2011     Document Type: Article

References (37)

1. Bindom SM, Hans CP, Xia H, Boulares AH, Lazartigues E. Angiotensin I converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Diabetes 59: 2540-2548, 2010.
2. Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 302: 193-202, 2009.
3. Burgelova M, Vanourkova Z, Thumova M, Dvorak P, Opocensky M, Kramer HJ, Zelizko M, Maly J, Bader L, Cervenka M. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J Hypertens 27: 1988-2000, 2009.
4. Carlos MF, Varagic J. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol 298: F1297-F1305, 2010.
5. Chu KY, Lau T, Carlsson PO, Leung PS. AT1 receptor blockade improves beta-cell function and glucose tolerance in mouse model of type 2 diabetes. Diabetes 55: 367-374, 2006.
6. Chu KY, Leung PS. Angiotensin II type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet b-cell function in young type 2 diabetic mice. Antioxid Redox Signal 9: 869-878, 2007.
7. Czaky TZ, Fisher E. Intestinal sugar transport in experimental diabetes. Diabetes 30: 568-574, 1981.
8. Debnam ES, Karasov WH. Nutrient uptake by rat enterocytes during diabetes mellitus: evidence for an increased sodium electrochemical gradient. J Physiol 397: 503-512, 1988.
9. Debnam ES, Smith MW, Sharp PA, Srai SK, Turvey A, Keable SJ. The effects of streptozotocin diabetes on sodium-glucose transporter (SGLT1) expression and function in rat jejunal and ileal villus-attached enterocytes. Europ J Physiol 430: 151-159, 1995.
10. Debnam ES, Unwin RJ. Hyperglycemia and intestinal and renal glucose transport: implications for diabetic renal injury. Kidney Int 50: 1101-1109, 1996.
11. Del Castillo JR. The use of hyperosmolar, intracellular-like solutions for the isolation of epithelial cells from guinea-pig small intestine. Biochim Biophys Acta 901: 201-208, 1987.
12. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
13. Ferrario CM, Varagic J. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol 298: F1297-F1305, 2010.
14. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol 290: C420-C426, 2006.
15. Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 295: H2373-H2379, 2008.
16. Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP, Siems WE, Walther T. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26: 1270-1277, 2005.
17. Ip SP, Wong TP, Tsai SJ, Leung PS. The recovery of some components of the renin angiotensin system in the rat pancreas after chronic exposure to hypoxic condition. J Mol Endocrinol 31: 563-571, 2003.
18. Jumarie C, Malo C. Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro. J Cell Physiol 149: 24-33, 1991.
19. Karasov WH, Diamond JM. A simple method for measuring intestinal solute uptake in vitro. J Comp Physiol 152: 105-116, 1983.
20. Keidar S, Strizevsky A, Raz A, Gamliel-Lazarovich A. ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects. Nephrol Dial Transplant 22: 597-601, 2007.
21. Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 54: 3056-3062, 2005.
22. Kellett GL, Brot-Laroche E, Marce OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Ann Rev Nutr 28: 1-20, 2008.
23. Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensingenerating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47: 240-248, 2004.
24. Lely AT, Hamming I, Van GH, Navis GJ. Renal ACE2 expression in human kidney disease. J Pathol 204: 587-593, 2004.
25. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol 580: 31-37, 2007.
26. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54: 1790-1796, 2005.
27. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383: 45-51, 2004.
28. Santos SH, Fernandes LR, Mario EG, Ferreira AV, Pô o LC, Alvarez- Leite JI, Botion LM, Bader M, Alenina N, Santos RA. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 57: 340-347, 2008.
29. Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva RA, Díez-Freire C, Dooies A, Jun JY, Sriramula S, Mariappan N, Pourang D, Venugopal CS, Francis J, Reudelhuber T, Santos RA, Patel JM, Raizada MK, Katovich MJ. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 182: H1065-H1072, 2010.
30. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the reninangiotensin system in the ZDF rat. Diabetes 53: 989-997, 2004.
31. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensinconverting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243, 2000.
32. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzymerelated carboxypeptidase. J Biol Chem 277: 14838-14843, 2002.
33. Wong TP, Debnam ES, Leung PS. Diabetes mellitus and expression of the enterocyte renin-angiotensin system: implications for control of glucose transport across the brush border membrane. Am J Physiol Cell Physiol 297: C601-C610, 2009.
34. Wong TP, Debnam ES, Leung PS. Involvement of an enterocyte reninangiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane. J Physiol 584: 613-623, 2007.
35. Wysocki J, Ye M, Rodriguez E, Gonzalez-Pacheco FR, Barrios C, Evora K, Schuster M, Loibner H, Brosnihan KB, Ferrario CM, Penninger JM, Batlle D. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension 55: 90-98, 2010.
36. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D. ACE and ACE2 activity in diabetic mice. Diabetes 55: 2132-2139, 2006.
37. Zhang J, Noble NA, Border WA, Huang Y. Infusion of angiotensin- (1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 298: F579-F588, 2010.